A recent study published by News Medical Life Sciences, citing the journal Biological Psychiatry, revealed that cardiovascular disease is the leading cause of premature death among patients with bipolar disorder. The study concluded that there are slight abnormalities in how the heart muscle functions and pumps blood in those affected by the disorder.
اضافة اعلان
Main findings of the study:
Early heart function impairment: The study, conducted on young people aged between 20 and 45, showed that heart muscle dysfunction is already evident in the early stages of bipolar disorder, before it progresses to heart failure.
Impact on the left ventricle: This is the first study of its kind to reveal that heart muscle dysfunction in bipolar disorder patients significantly affects parts of the left ventricle supplied by major coronary arteries.
Possible link to vascular weakness: The results suggest a potential connection between bipolar disorder and underlying coronary vascular weakness, increasing the risk of cardiovascular disease.
According to the study, patients with bipolar disorder are about twice as likely to develop heart failure compared to non-affected individuals. These findings open new horizons for developing treatments aimed at preventing the worsening of heart failure in this high-risk group.
Main findings of the study:
Early heart function impairment: The study, conducted on young people aged between 20 and 45, showed that heart muscle dysfunction is already evident in the early stages of bipolar disorder, before it progresses to heart failure.
Impact on the left ventricle: This is the first study of its kind to reveal that heart muscle dysfunction in bipolar disorder patients significantly affects parts of the left ventricle supplied by major coronary arteries.
Possible link to vascular weakness: The results suggest a potential connection between bipolar disorder and underlying coronary vascular weakness, increasing the risk of cardiovascular disease.
According to the study, patients with bipolar disorder are about twice as likely to develop heart failure compared to non-affected individuals. These findings open new horizons for developing treatments aimed at preventing the worsening of heart failure in this high-risk group.
